These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11977405)

  • 1. An industry commentary on regulatory issues--microbiology.
    Moldenhauer JE
    PDA J Pharm Sci Technol; 2002; 56(2):60-4. PubMed ID: 11977405
    [No Abstract]   [Full Text] [Related]  

  • 2. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 4. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP and PET radiopharmaceuticals: 1997 FDAMA puts standard-setting body at center of regulatory process.
    Hung JC; Callahan RJ
    J Nucl Med; 2004 Jan; 45(1):13N-14N, 16N. PubMed ID: 14734661
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
    J Parenter Sci Technol; 1988; 42(4):105. PubMed ID: 3183862
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2009; (953):1-161. PubMed ID: 19621561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
    Tidswell EC; Tirumalai RS; Gross DD
    PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4A on Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15991-2. PubMed ID: 19507322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4B on Microbiological Examination of nonsterile products: Tests for Specified Microorganisms General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15989-90. PubMed ID: 19507320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative studies for the establishment of reference substances for the microbiological assay of antibiotics.
    Charton E; Daas AG; Sandrin J; Miller JH
    Pharmeuropa Bio; 2004 Jan; 2003(2):1-8. PubMed ID: 14960259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 16. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of reference extracts in quality control of traditional Chinese medicines].
    Lu TL; Zhai WM; Cai BC; Zhou Y; Mao CQ; Li L
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):462-5. PubMed ID: 23668030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.
    Miller DG
    Int J Pharm Compd; 2014; 18(2):117-8. PubMed ID: 24881114
    [No Abstract]   [Full Text] [Related]  

  • 19. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 20. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.